FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))

View source ↗

Summary

FDA approved a supplemental application for Vizamyl (flutemetamol F-18) submitted by GE Healthcare Inc. The action updates the regulatory status of Vizamyl.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• VIZAMYL (Flutemetamol F-18)

Snippet

SUPPL AP for VIZAMYL (FLUTEMETAMOL F-18)